Resources
Filters
Boston University, Evidation publish study on voice as a digital marker in detection of Alzheimer’s disease
Boston University, Evidation publish study on voice as a digital marker in detection of Alzheimer’s disease
Boston University, Evidation publish study on voice as a digital marker in detection of Alzheimer’s disease

Boston University, Evidation publish study on voice as a digital marker in detection of Alzheimer’s disease
Evidation researchers, alongside researchers at Boston University School of Medicine, have announced the publication of study results that examine the use of voice recordings and transcripts as potential diagnostic tools for Alzheimer's Disease.

Cognitive digital biomarkers for automated transcription of spoken language
Cognitive digital biomarkers for automated transcription of spoken language
N. Tavabi, D. Stück, A. Signorini, C. Karjadi, T. Al Hanai, M. Sandoval, C. Lemke, J. Glass, S. Hardy, M. Lavallee, B. Wasserman, T. F. A. Ang, C. M. Nowak, R. Kainkaryam, L. Foschini & Rhoda Au
Cognitive digital biomarkers for automated transcription of spoken language
N. Tavabi, D. Stück, A. Signorini, C. Karjadi, T. Al Hanai, M. Sandoval, C. Lemke, J. Glass, S. Hardy, M. Lavallee, B. Wasserman, T. F. A. Ang, C. M. Nowak, R. Kainkaryam, L. Foschini & Rhoda Au
Cognitive digital biomarkers for automated transcription of spoken language
Evidation research reveals that the use of voice-based digital biomarkers might be a valuable tool in detecting and differentiating mild cognitive impairment and dementia
N. Tavabi, D. Stück, A. Signorini, C. Karjadi, T. Al Hanai, M. Sandoval, C. Lemke, J. Glass, S. Hardy, M. Lavallee, B. Wasserman, T. F. A. Ang, C. M. Nowak, R. Kainkaryam, L. Foschini & Rhoda Au

Influence of digital intervention messaging on influenza vaccination rates among adults with cardiovascular disease in the United States: A decentralized randomized clinical trial
Influence of digital intervention messaging on influenza vaccination rates among adults with cardiovascular disease in the United States: A decentralized randomized clinical trial
Nell J. Marshall, Jennifer L. Lee, Jessica Schroeder, Wei-Nchih Lee, Jermyn See, Mohammad Madjid, Mrudula R. Munagala, John D. Piette, Litjen Tan, Orly Vardeny, Michael Greenberg, Jan Liska, Monica Mercer, Sandrine Samson
Influence of digital intervention messaging on influenza vaccination rates among adults with cardiovascular disease in the United States: A decentralized randomized clinical trial
Nell J. Marshall, Jennifer L. Lee, Jessica Schroeder, Wei-Nchih Lee, Jermyn See, Mohammad Madjid, Mrudula R. Munagala, John D. Piette, Litjen Tan, Orly Vardeny, Michael Greenberg, Jan Liska, Monica Mercer, Sandrine Samson
Influence of digital intervention messaging on influenza vaccination rates among adults with cardiovascular disease in the United States: A decentralized randomized clinical trial
Evidation research reveals that a personalized, evidence-based digital intervention could be effective in increasing vaccination rates in a population of high-risk people with cardiovascular disease.
Nell J. Marshall, Jennifer L. Lee, Jessica Schroeder, Wei-Nchih Lee, Jermyn See, Mohammad Madjid, Mrudula R. Munagala, John D. Piette, Litjen Tan, Orly Vardeny, Michael Greenberg, Jan Liska, Monica Mercer, Sandrine Samson

Using digital health technologies to transform community health and health equity
Using digital health technologies to transform community health and health equity
Using digital health technologies to transform community health and health equity
Using digital health technologies to transform community health and health equity
Evidation responded to an RFI from the White House Office of Science and Technology Policy (OSTP) to provide input on how digital health tools can transform community health and health equity.

The n-of-1 that counts
The n-of-1 that counts
Eric J. Daza
The n-of-1 that counts
Eric J. Daza

The n-of-1 that counts
Elvira’s story shows us the amazing potential for n-of-1 trials and SCEDs to help each of us figure out exactly what’s going on in our own lives. They can help us use our own PGHD to determine what actually influences our own health each and every day, regardless of how those same triggers harm—or may even help—others.
Eric J. Daza

Measuring health-related quality of life with multimodal data: Viewpoint
Measuring health-related quality of life with multimodal data: Viewpoint
Ieuan Clay, Francesca Cormack, Szymon Fedor, Luca Foschini, Giovanni Gentile, Chris van Hoof, Priya Kumar, Florian Lipsmeier, Akane Sano, Benjamin Smarr, Benjamin Vandendriessche, Valeria De Luca
Measuring health-related quality of life with multimodal data: Viewpoint
Ieuan Clay, Francesca Cormack, Szymon Fedor, Luca Foschini, Giovanni Gentile, Chris van Hoof, Priya Kumar, Florian Lipsmeier, Akane Sano, Benjamin Smarr, Benjamin Vandendriessche, Valeria De Luca
Measuring health-related quality of life with multimodal data: Viewpoint
Evidation contributed to a summary of how multimodal technologies capable of measuring several modalities simultaneously provide value to stakeholders.
Ieuan Clay, Francesca Cormack, Szymon Fedor, Luca Foschini, Giovanni Gentile, Chris van Hoof, Priya Kumar, Florian Lipsmeier, Akane Sano, Benjamin Smarr, Benjamin Vandendriessche, Valeria De Luca

Evidation partners with other industry leaders to launch resources to drive inclusion in digital health measurement
Evidation partners with other industry leaders to launch resources to drive inclusion in digital health measurement
Evidation partners with other industry leaders to launch resources to drive inclusion in digital health measurement

Evidation partners with other industry leaders to launch resources to drive inclusion in digital health measurement
Evidation and other members of the Digital Health Measurement Collaborative Community (DATAcc) announced a new set of open-access resources to guide inclusivity in digital health measurement products from development to deployment.

Next generation patient engagement & enriched insights
Next generation patient engagement & enriched insights
Next generation patient engagement & enriched insights

Next generation patient engagement & enriched insights
Evidation has written a white paper that takes a closer look at the challenges of PGHD, its value to clinical decision makers, and how to contextualize it to optimize its value.

COPD — Determine high-impact clinical markers with person-generated health data (PGHD)
COPD — Determine high-impact clinical markers with person-generated health data (PGHD)
COPD — Determine high-impact clinical markers with person-generated health data (PGHD)

COPD — Determine high-impact clinical markers with person-generated health data (PGHD)
Combining activity and behavioral-related data can predict exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients

Estimating the burden of influenza-like illness on daily activity at the population scale using commercial wearable sensors
Estimating the burden of influenza-like illness on daily activity at the population scale using commercial wearable sensors
Aziz Mezlini, Allison Shapiro, Eric J. Daza, Eamon Caddigan, Ernesto Ramirez, Tim Althoff, Luca Foschini
Estimating the burden of influenza-like illness on daily activity at the population scale using commercial wearable sensors
Aziz Mezlini, Allison Shapiro, Eric J. Daza, Eamon Caddigan, Ernesto Ramirez, Tim Althoff, Luca Foschini
Estimating the burden of influenza-like illness on daily activity at the population scale using commercial wearable sensors
Evidation research reveals that most of the burden of influenza-like illness is invisible to health care and public health reporting systems.
Aziz Mezlini, Allison Shapiro, Eric J. Daza, Eamon Caddigan, Ernesto Ramirez, Tim Althoff, Luca Foschini

No results found. Try broadening your search for more results!